DK595987A - Osmotisk kontinuerligt dispenserende oralt afgivelsessystem indeholdende et moderat vandoploeseligt metoprololsalt - Google Patents

Osmotisk kontinuerligt dispenserende oralt afgivelsessystem indeholdende et moderat vandoploeseligt metoprololsalt

Info

Publication number
DK595987A
DK595987A DK595987A DK595987A DK595987A DK 595987 A DK595987 A DK 595987A DK 595987 A DK595987 A DK 595987A DK 595987 A DK595987 A DK 595987A DK 595987 A DK595987 A DK 595987A
Authority
DK
Denmark
Prior art keywords
delivery system
water soluble
system containing
core
oral delivery
Prior art date
Application number
DK595987A
Other languages
English (en)
Other versions
DK595987D0 (da
Inventor
Shih-Wei Lee
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK595987D0 publication Critical patent/DK595987D0/da
Publication of DK595987A publication Critical patent/DK595987A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK595987A 1986-11-14 1987-11-13 Osmotisk kontinuerligt dispenserende oralt afgivelsessystem indeholdende et moderat vandoploeseligt metoprololsalt DK595987A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93082886A 1986-11-14 1986-11-14

Publications (2)

Publication Number Publication Date
DK595987D0 DK595987D0 (da) 1987-11-13
DK595987A true DK595987A (da) 1988-05-15

Family

ID=25459837

Family Applications (1)

Application Number Title Priority Date Filing Date
DK595987A DK595987A (da) 1986-11-14 1987-11-13 Osmotisk kontinuerligt dispenserende oralt afgivelsessystem indeholdende et moderat vandoploeseligt metoprololsalt

Country Status (14)

Country Link
EP (1) EP0271438B1 (da)
JP (1) JP2567427B2 (da)
KR (1) KR960002180B1 (da)
AT (1) ATE75394T1 (da)
AU (1) AU598318B2 (da)
CA (1) CA1312016C (da)
DE (1) DE3778662D1 (da)
DK (1) DK595987A (da)
ES (1) ES2032205T3 (da)
GR (1) GR3005132T3 (da)
IE (1) IE60533B1 (da)
NZ (1) NZ222525A (da)
PT (1) PT86119B (da)
ZA (1) ZA878526B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
KR100733925B1 (ko) * 2005-03-16 2007-07-02 주식회사 엘지화학 ECD(Electro Chromic Device) 제어 장치
IL210279A0 (en) 2009-12-25 2011-03-31 Dexcel Pharma Technologies Ltd Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
GB8503666D0 (en) * 1985-02-13 1985-03-13 Shell Int Research Producing 4-(2-methoxyethyl)-phenylglycidyl ether
US5019302A (en) * 1986-03-12 1991-05-28 Washington University Technology Associates, Inc. Method for granulation

Also Published As

Publication number Publication date
PT86119B (pt) 1990-08-31
KR880005944A (ko) 1988-07-21
JPS63135329A (ja) 1988-06-07
IE873071L (en) 1988-05-14
PT86119A (en) 1987-12-01
ATE75394T1 (de) 1992-05-15
EP0271438A3 (en) 1989-07-19
AU8119287A (en) 1988-05-19
CA1312016C (en) 1992-12-29
EP0271438B1 (de) 1992-04-29
JP2567427B2 (ja) 1996-12-25
DK595987D0 (da) 1987-11-13
GR3005132T3 (da) 1993-05-24
EP0271438A2 (de) 1988-06-15
DE3778662D1 (de) 1992-06-04
IE60533B1 (en) 1994-07-27
NZ222525A (en) 1989-12-21
ES2032205T3 (es) 1993-01-16
AU598318B2 (en) 1990-06-21
KR960002180B1 (ko) 1996-02-13
ZA878526B (en) 1988-05-16

Similar Documents

Publication Publication Date Title
FI69564B (fi) Doseringsenhet foer kontrollerad frigoering av ett terapeutiskt aktivt medel
ATE310508T1 (de) Therapeutische formulierung enthaltende dosierungsform
ZA87153B (en) Pseudoephedrine,brompheniramine therapy
DE69020422T2 (de) Zusammensetzung in Form eines Schaumes enthaltend 5-Aminosalicylic Säure zur intra-rektal Verabreichung.
NO175186C (no) Fremgangsmåte for fremstilling av et osmotisk avgivende, oralt avleveringssystem inneholdende et moderat vannopplöselig, farmasöytisk akseptabelt salt av metoprolol
NZ216035A (en) Fine tubular drug compositions
IE882898L (en) Solubility modulated drug delivery device
IE891919L (en) Pharmaceutical dosage form for the medication of fish
ES551674A0 (es) Procedimiento para la preparacion de liposomas a partir de una mezcla de un componente lipido y agua
DK595987D0 (da) Osmotisk kontinuerligt dispenserende oralt afgivelsessystem indeholdende et moderat vandoploeseligt metoprololsalt
JPS57126420A (en) Drug for digestive organ
JPS57146723A (en) Pharmaceutical preparation having improved absorption
SE8106498L (sv) Kvaternera salter av n,n3-di(beta-brompropionyl)-n1,n2-dispirotripiperazinium, forfarande for framstellning av desamma och lekemedelspreparat innehallande desamma
SI8810221B (sl) Postopek za pripravo oralnega terapevtskega sistema
GT198170908A (es) Suspension de sal de adicion de acido de bacampicilina microencapsulada para administracion oral, especialmente pediatrica.
DE29909986U1 (de) Stabile Arzneilösung umfassend Epirubicin und Puffersubstanzen
JPS57114517A (en) Antidiabetic agent

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment